ArticleTherapeutic advances in neurological disorders2026
Prediction of cognitive impairment in epilepsy with spike-and-wave activation in sleep based on EEG.
Article in Therapeutic advances in neurological disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Spike-and-wave activation in sleep (SWAS) may lead to irreversible cognitive impairment, progressing to epileptic encephalopathy (EE)-SWAS. However, existing EEG studies have not differentiated between SWAS patients based on their future cognitive outcomes. Objectives: This study aims to extract features from the sleep EEG of SWAS patients and develop a machine learning model to predict cognitive outcomes. Design: A retrospective study. Methods: A retrospective analysis was conducted on the sleep EEG obtained during the interictal period of 41 SWAS patients (15 with cognitive impairment). Cognitive impairment prediction models (support vector machine (SVM) and light gradient boosting machine (LightGBM)) were constructed based on spike-wave index (SWI) (the gold standard for diagnosing SWAS) and multidimensional EEG features, including functional connectivity (FC), minimum spanning tree (MST), and time-frequency-nonlinear (TFN) features, alongside a multidomain fusion (MDF) model integrating all feature sets. The performance of these EEG-based models was compared with the SWI model. Results: Models using the single SWI feature showed limited predictive capability (highest ACC: 0.756, AUC: 0.749). Conversely, multidimensional EEG models demonstrated superior performance. Specifically, the FC-based SVM model achieved the highest accuracy (0.873). Furthermore, MDF-based LightGBM models outperformed all single-feature-set models in overall discriminative capability (highest AUC: 0.934). These findings highlight the superiority of multidimensional EEG features over SWI for predicting cognitive outcomes in SWAS. Conclusion: The developed EEG-based machine learning models hold potential to assist in early cognitive prediction and treatment decisions for SWAS patients. However, given the current methodological limitations, further clinical verification is warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.